HR 6214119th CongressIn Committee

Kidney Care Access Protection Act

Standard Summary
Balanced plain-English summary

This bill would amend Medicare payment rules to improve access to innovative treatments for end-stage renal disease. It extends transitional add-on payments for new kidney dialysis drugs, biologicals, and devices; creates a permanent post-transitional drug adjustment; addresses Medicare Advantage payment for innovative kidney therapies; adjusts dialysis payment updates for forecast error; and expands Medicare coverage for kidney disease screening and education.

Key Points

  • 1Extends and modifies Medicare add-on payments for new renal dialysis drugs, biologicals, and devices.
  • 2Creates a permanent post-TDAPA payment adjustment for certain kidney care drugs and biologicals.
  • 3Requires Medicare Advantage direct payment adjustments for innovative kidney therapies.
  • 4Expands Medicare annual wellness benefits to include chronic kidney disease screening.
  • 5Broadens access to Medicare kidney disease education, including through renal dialysis facilities.

Impact Areas

End-stage renal disease patientsDialysis facilitiesMedicare Advantage enrolleesKidney care drug and device manufacturersMedicare providers and suppliers
Generated by deepseek/deepseek-v4.1-flash-1017Nov 18, 2026